The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems, providing an alternative to comparator products and lowering price ...

The past 18 months has presented the generics and brand pharmaceutical industries with a dilemma unique to the US market: whether a partnership to launch and market a generic version of the brand's ...